Scientists zap tumors to boost immune attack on cancer
NCT ID NCT02642809
Summary
This small, early-stage study tested a two-part treatment for advanced esophageal cancer that had spread. First, doctors used a short, intense course of targeted radiation on the main tumor in the esophagus. The goal was to 'wake up' the patient's own immune system to fight the cancer. Then, they gave an immunotherapy drug (pembrolizumab) to help the immune system attack cancer cells throughout the body. The main goal was to see if this combination was safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.